Articles Tagged With:
-
Research Group Increased Minority Participation by 533%
One barrier to enrolling minorities in research involves resources. For some studies, such as pediatric oncology clinical trials, there might not be enough resources to enroll one or two patients at a single site.
-
Diversity and Inclusion Go Beyond Race and Ethnicity
Researchers assessing the demographic statistics of All of Us Research Program participants prioritized enrolling racial, ethnic, and other minorities that, historically, have been underrepresented in clinical trials. The researchers concluded studies need to incorporate more diverse factors as key variables to ensure inclusion and identify barriers that limit research participation.
-
Research Community Seeks to Enroll More Minorities in Clinical Trials
Several months of data from the COVID-19 pandemic showed that African Americans and other people of color were disproportionately dying from the disease. Disparities in how COVID-19 affects minority communities highlight long-standing difficulties in achieving health equity in U.S. society, including clinical trials.
-
Understanding Cannabidiol (CBD)
Cannabidiol is used by a growing population for many ailments. Although not typically an emergency drug, it has important interactions and a few side effects that can be seen in the emergency department.
-
Study: No Relationship Between Blood Type, COVID-19 Severity
But those with certain blood types may be at higher risk for testing positive.
-
White Paper Calls for Overhaul of Federal Nutrition Research
Coalition of experts say extra funding, better coordination needed to improve public health.
-
Protect the Brain from Air Pollution with … Fish?
Researchers observed better white matter preservation in those who consumed more omega-3 fatty acids.
-
Stroke Risk and Social Determinants of Health
Income levels, health insurance access among several factors researchers connected to incident stroke events.
-
We’d Love to Hear from You!
Please complete our annual reader survey (https://bit.ly/2XYHWdM).
-
The ABCs of CBD: The Fundamentals of Cannabidiol
Cannabidiol (CBD) is one of two major constituents of marijuana and is the non-psychoactive component of cannabis. As its popularity has grown, questions about CBD from patients to their primary care clinicians have increased dramatically. As a patient advocate interpreting the available evidence, the primary care clinician needs to recognize how CBD differs from marijuana, what its clinical utility might be, and what its risks are.